These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 36083928)
1. An unsupervised region of interest extraction model for tau PET images and its application in the diagnosis of Alzheimer's disease. Shi R; Wang L; Jiang J Annu Int Conf IEEE Eng Med Biol Soc; 2022 Jul; 2022():2157-2160. PubMed ID: 36083928 [TBL] [Abstract][Full Text] [Related]
2. Detection of individual brain tau deposition in Alzheimer's disease based on latent feature-enhanced generative adversarial network. Jiang J; Shi R; Lu J; Wang M; Zhang Q; Zhang S; Wang L; Alberts I; Rominger A; Zuo C; Shi K; Neuroimage; 2024 May; 291():120593. PubMed ID: 38554780 [TBL] [Abstract][Full Text] [Related]
3. Quantitative Zhao Q; Liu M; Ha L; Zhou Y; Front Neurol; 2019; 10():486. PubMed ID: 31156534 [TBL] [Abstract][Full Text] [Related]
4. Generation of Conventional Choi HJ; Seo M; Kim A; Park SH Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512092 [No Abstract] [Full Text] [Related]
5. BPGAN: Brain PET synthesis from MRI using generative adversarial network for multi-modal Alzheimer's disease diagnosis. Zhang J; He X; Qing L; Gao F; Wang B Comput Methods Programs Biomed; 2022 Apr; 217():106676. PubMed ID: 35167997 [TBL] [Abstract][Full Text] [Related]
6. Unsupervised detection of individual atrophy in Alzheimer's disease. Jin S; Zou P; Han Y; Jiang J Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():2647-2650. PubMed ID: 34891796 [TBL] [Abstract][Full Text] [Related]
7. Deep convolutional generative adversarial network for Alzheimer's disease classification using positron emission tomography (PET) and synthetic data augmentation. Sajjad M; Ramzan F; Khan MUG; Rehman A; Kolivand M; Fati SM; Bahaj SA Microsc Res Tech; 2021 Dec; 84(12):3023-3034. PubMed ID: 34245203 [TBL] [Abstract][Full Text] [Related]
8. Sex modulates the ApoE ε4 effect on brain tau deposition measured by Liu M; Paranjpe MD; Zhou X; Duy PQ; Goyal MS; Benzinger TLS; Lu J; Wang R; Zhou Y Theranostics; 2019; 9(17):4959-4970. PubMed ID: 31410194 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic value of amyloid PET textural and shape features: comparison with classical semi-quantitative rating in 760 patients from the ADNI-2 database. Ben Bouallègue F; Vauchot F; Mariano-Goulart D; Payoux P Brain Imaging Behav; 2019 Feb; 13(1):111-125. PubMed ID: 29427064 [TBL] [Abstract][Full Text] [Related]
13. Association between long-term donepezil treatment and brain regional amyloid and tau burden among individuals with mild cognitive impairment assessed using Li J; Zheng C; Ge Q; Yan S; Paranjpe MD; Hu S; Zhou Y; J Neurosci Res; 2022 Feb; 100(2):670-680. PubMed ID: 34882830 [TBL] [Abstract][Full Text] [Related]
14. Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease. Imabayashi E; Tamamura N; Yamaguchi Y; Kamitaka Y; Sakata M; Ishii K Ann Nucl Med; 2022 Oct; 36(10):865-875. PubMed ID: 35821311 [TBL] [Abstract][Full Text] [Related]
15. Deep learning detection of informative features in tau PET for Alzheimer's disease classification. Jo T; Nho K; Risacher SL; Saykin AJ; BMC Bioinformatics; 2020 Dec; 21(Suppl 21):496. PubMed ID: 33371874 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders. Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858 [TBL] [Abstract][Full Text] [Related]
17. Ensembles of Deep Learning Architectures for the Early Diagnosis of the Alzheimer's Disease. Ortiz A; Munilla J; Górriz JM; Ramírez J Int J Neural Syst; 2016 Nov; 26(7):1650025. PubMed ID: 27478060 [TBL] [Abstract][Full Text] [Related]
18. Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography. Meyer PF; Pichet Binette A; Gonneaud J; Breitner JCS; Villeneuve S JAMA Neurol; 2020 Apr; 77(4):508-516. PubMed ID: 31961372 [TBL] [Abstract][Full Text] [Related]
20. Combination of automated brain volumetry on MRI and quantitative tau deposition on THK-5351 PET to support diagnosis of Alzheimer's disease. Kim M; Kim SJ; Park JE; Yun J; Shim WH; Oh JS; Oh M; Roh JH; Seo SW; Oh SJ; Kim JS Sci Rep; 2021 May; 11(1):10343. PubMed ID: 33990649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]